News

India’s green energy ambitions received a solid push from the Indian Renewable Energy Development Agency’s (IREDA) robust results for the fourth quarter of the financial year 2024–25. The company’s shares rallied 6% as it reported a 49% year-on-year jump in net profit, reaching ₹502 crore in Q4, up from ₹337 crore during the same period last year. Revenue also went up 37%, coming in at ₹1,904 crore for the quarter. 

Following the announcement, IREDA’s share price traded at around ₹176 on the BSE and NSE, hitting a high of ₹179.50 intraday.

Beyond the numbers, the jump indicates IREDA’s growing importance in India’s renewable energy ecosystem, its performance post-IPO, and what these results could mean for investors going forward.

IREDA’s Record-Breaking FY2024- 25

Here are the key financial highlights of IREDA from the January–March quarter (Q4 FY25):

• Total Revenue from Operations
  • ₹1,905 crore in Q4 FY25
  • ₹1,698.45 in Q3FY25, up by 35.6%
  • Up 37% from ₹1,391 crore in Q4 FY24
    
• Profit After Tax (PAT)
  • ₹502 crore in Q4 FY25
  • Up 18% from ₹425 crore in Q3 FY25
  • Up 12% quarter-on-quarter from ₹1,698 crore in Q3 FY25
    
• Gross Non-Performing Assets (GNPA)
• ₹1,866 crore in Q4 FY25
  • Compared to ₹1,845 crore in Q3 FY25
  • Higher than ₹1,411 crore in Q4 FY24

Source: Economic Times

These numbers are no small feat for a government-owned lender, especially in a complex and evolving sector like renewables.

IREDA’s Post-IPO Performance

IREDA made its stock market debut in November 2023 with a blockbuster listing. The IPO was oversubscribed over 38 times, and the stock listed at a premium of 56% to its issue price of ₹32 per share.

Since then, the stock has seen multiple rallies. Even though it’s currently trading below its all-time high of ₹215 (hit in February 2024), it remains well above the IPO price, delivering over 4X returns for early investors in less than six months.

What’s fuelling this consistent market interest? A mix of factors:

• Strong financial performance
• The government focuses on renewables
• Investor interest in sustainable finance
• The company’s plan to expand lending capacity

IREDA is now considered one of the country’s strongest government-backed green finance platforms. Source: Economic Times

Future Plans: ₹5,000 Crore QIP and Stake Dilution

To meet rising demand and expand its lending book, IREDA plans to raise ₹5,000 crore through a Qualified Institutional Placement (QIP). This was recently approved by shareholders and is expected to occur in the coming quarters.

This fundraiser will likely dilute the government’s stake by about 7%, but analysts see the move as positive. More capital means IREDA can fund bigger projects and take on more clients without stressing its balance sheet.

If the plan works, it could help IREDA strengthen its market position further, both as a lender and as a listed company. Source: Press Information Bureau

Market Response and Analyst View

Markets responded quickly to the Q4 results. IREDA stock rose by 6% on the day of the announcement (April 16), driven by higher-than-expected profit and revenue figures. The volume of trades also surged, indicating institutional interest.

Analysts believe the company is well-placed for long-term growth. A relatively low GNPA ratio, robust capital structure, and clear policy direction from the government are all working in its favour.

Why IREDA’s Growth Matters

Under the Ministry of New and Renewable Energy (MNRE), IREDA is key in funding India’s renewable energy projects—solar parks, wind farms, bioenergy, hydroelectricity, and energy efficiency projects. It works like a non-banking financial institution (NBFC), and lends specifically to businesses and projects that contribute to India’s clean energy targets. As those targets are massive—500 GW of non-fossil fuel energy capacity by 2030, IREDA is expected to finance a major portion of that transition. 

So, when IREDA grows financially, it means more funding for green energy, and that’s a win for investors and the planet too. Its loans help build wind farms, solar rooftops, biofuel projects, and energy-efficient buildings across India.

As the country eyes global leadership in the fight against climate change, IREDA’s success sends a strong message: that green financing can be good business, too.

What it Means for the Investors

IREDA offers investors a unique opportunity—exposure to clean energy, backed by the government, with promising growth potential. The 6% rally signals renewed investor confidence in the company’s growth story and financial strength. 

For existing shareholders, it reinforces the long-term potential of holding a stock not only backed by the government but also strategically positioned in India’s renewable energy expansion. 

For new investors, the sharp rise—triggered by a 49% jump in quarterly profit—suggests that the stock still has momentum, especially with IREDA planning to raise fresh capital to scale operations. 

While short-term rallies often reflect immediate market sentiment, in IREDA’s case, they also hint at broader optimism about the clean energy financing space and the company’s ability to play a pivotal role.

Conclusion

IREDA’s revenue and profit growth signal progress toward a greener, more energy-secure future. As the stock stabilizes and prepares for further capital expansion, all eyes will be on how IREDA manages its next growth phase. If it keeps this pace up, it may become one of Asia’s most influential green finance players.

Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis – Research & Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL & the certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.

What Does the Executive Order Include?

Trump’s executive order comprises several core reforms:

1. International Reference Pricing: Drug prices under Medicare will be benchmarked against those in Canada, Germany, and Australia.
   
2. Import Expansion: The FDA will expedite pathways for importing low-cost generics and biosimilars.
   
3. Hospital Procurement Reforms: Hospitals under federal programs must prioritize cost-effective suppliers.
   
4. Patent Review and Reuse Policy: The administration will incentivize generic manufacturing and challenge anti-competitive patent extensions.
   

These changes, aimed at breaking monopolistic pricing, also signal that the U.S. is ready to embrace cheaper imports to protect domestic affordability.  Source: New York Times, April 15, 2025

India’s Competitive Advantage in a New Global Pharma Order

India, known as the “pharmacy of the world,” already accounts for 20% of global generics exports by volume, according to Statista. The U.S. is its largest market, accounting for nearly 32% of India’s pharma exports in FY2024. 

Here are two key insights to know about

1. India vs China – FDA-Approved Facilities: India leads with over 750 U.S. FDA-approved pharma plants, compared to China’s ~120.
   
2. India’s Pharma Export Share: The U.S. is India’s top destination for pharma exports, accounting for 32% of total shipments in FY2024.

With the U.S. government actively looking to bring down prices, Indian manufacturers offering cost savings of 30–70% over Western peers are in a strong position. Companies like Sun Pharma, Dr. Reddy’s Laboratories, Cipla, and Aurobindo are well-placed due to their robust regulatory compliance and existing U.S. FDA-approved manufacturing facilities.  

Metric	Current (2024)	Post-Order Estimate (2025-26)
India Pharma Exports to the U.S.	$8.2 billion	$10.5–$12 billion
U.S. Generic Drug Imports	$58 billion	$65–$70 billion
% of U.S. generics from India	40%	>50%
U.S. Drug Cost Savings	—	$30 billion (Est. by 2026)

Sources: Reuters, Economic Times, U.S. Congressional Budget Office Estimates

Winners and Losers

Winners:

• Indian Generics Manufacturers: Cost arbitrage, quality compliance, and scalability give India the edge. 
• U.S. Healthcare Consumers: The executive order could cut average prescription costs by 15–20%.
• Emerging Market Drugmakers: Especially those compliant with U.S. FDA standards, like those in Brazil or Vietnam.

Losers:

• Big Pharma (U.S. and Europe): The directive threatens R&D-heavy firms that depend on pricing power in the U.S. for profitability.
  
• Non-compliant Foreign Suppliers: China and other low-cost regions lacking U.S. FDA approvals might struggle to meet new import standards. 

Challenges for Indian Pharma: Not All Smooth Sailing

While Trump’s executive order presents a historic growth window for India’s pharmaceutical sector, several structural and economic challenges must be addressed before Indian drugmakers can fully seize the opportunity.

1. Regulatory Compliance & Inspection Risk

The U.S. Food and Drug Administration (FDA) has significantly ramped up its overseas inspection frequency, particularly for Indian plants. According to the FDA’s FY2023 inspection data, Indian pharma plants accounted for over 30% of all global warning letters. Even a minor deviation in quality control can lead to import alerts or plant bans.

Example: In early 2023, Aurobindo Pharma faced delays in product launches after the FDA flagged deficiencies at its Telangana unit. Such disruptions can translate into lost revenue and reduced credibility in the U.S. market.

2. Overdependence on China for APIs

Despite India’s strength in finished formulations, it still imports nearly 65% of its bulk drugs (APIs) from China, according to India’s Ministry of Chemicals and Fertilizers. Any disruption in India-China trade, whether geopolitical or logistical, could bottleneck the ability of Indian firms to meet increased demand from the U.S.

While the Production Linked Incentive (PLI) Scheme for APIs aims to reduce this dependence, it is still in the early execution stages and not yet impactful at scale.

3. Pricing Pressure and Margin Squeeze

Greater volume doesn’t always mean higher profitability. The U.S. generics market has become intensely competitive. The average price erosion for Indian generics in the U.S. stood at 8–10% in FY2024, according to ICRA. This price war, exacerbated by group purchasing organizations (GPOs), can severely impact profit margins even as top-line revenue grows.

4. Skilled Manpower and Capacity Constraints

Companies will need to ramp up manufacturing capacities to meet elevated global demand. But this brings logistical challenges regarding trained workforce, technology upgrades, and ensuring 24/7 operations at FDA-approved sites. Such an expansion push could strain operational resilience in an industry already at ~75% utilization.

5. Trade Policy Uncertainty

India also faces uncertainties around U.S. trade preferences. The Generalized System of Preferences (GSP), which India previously benefited from, remains suspended. Without favorable trade terms or tariff reductions, Indian exports may face cost disadvantages despite demand tailwinds.

Global Ripple Effects: A Realignment in Healthcare Economics

Trump’s pricing overhaul isn’t just a U.S. domestic policy — it sends shockwaves across the global pharmaceutical supply chain and may accelerate long-term systemic shifts.

1. The Decline of Big Pharma Pricing Power

The executive order undermines the high-margin model of the U.S. and EU-based Big Pharma, which has traditionally relied on the U.S. market to recover R&D costs. With drug markups of up to 400–800% over manufacturing cost, the forced price benchmarking could pressure revenues and pipeline investments.

According to the Congressional Budget Office, the directive could reduce branded drugmakers’ annual revenues by $45–$60 billion over five years, forcing a revaluation of R&D-heavy portfolios.

2. The China Conundrum

China has long aimed to challenge India in the generics space, but lacks equivalent FDA penetration. As of 2024, India held 750+ U.S. FDA-approved facilities, compared to under 120 for China. The U.S.’s current geopolitical posture makes it unlikely to prefer deeper Chinese dependence in critical health sectors.

However, China’s dominant position in APIs still gives it bargaining power. Any retaliatory move in bulk drug exports could affect multiple nations, including the U.S., creating a policy paradox: push India for finished drugs, but rely on China for ingredients.

3. Opportunity for Secondary Players

Countries like Vietnam, Bangladesh, and Mexico, with lower-cost labor and improving regulatory ecosystems, may emerge as alternative suppliers, especially for less complex generics. Given its proximity to the U.S., Mexico may benefit from USMCA trade benefits and logistics efficiency.

Still, India’s established compliance and scale will likely remain the top beneficiary, at least in the short to medium term.

4. EU and Japan May Follow the U.S. Lead

Analysts from McKinsey and Brookings suggest that the U.S. move could pressure other developed markets to reevaluate their drug pricing and procurement models. Germany and France have already hinted at examining their hospital procurement supply chains post-COVID-19 disruptions. If it can diversify export destinations, India could gain across multiple continents. 

A Defining Opportunity for India’s Pharma Sector

Though controversial domestically, Trump’s drug pricing directive provides a strong external tailwind to India’s pharmaceutical exports. With the right mix of regulatory compliance, production scaling, and strategic alliances, India could significantly increase its global pharma share in the coming years.

However, to fully capitalize, Indian companies must double down on:

• FDA-compliant manufacturing.
• Diversifying API supply chains.
• Investing in biosimilars and specialty generics.
  

This could be a defining moment, not just for profits, but for India’s global positioning in healthcare economics.

Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis – Research & Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL & the certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.

With global markets continuing to swing to the tunes of the US’s tariff flip-flops, benchmark indices in India gained over 2% on Tuesday, 15th April 2025. Notably, it became the first major market to recoup the losses made since the reciprocal tariffs were first announced on 2nd April 2025. While the primary indices are closing on a positive note, another stock that made it to the green light zone is the stock of Paytm’s parent company, One97 Communications Limited. What was the surge, and what caused the rise in Paytm share price? Let’s decode.

Overview Of One 97 Communications Limited (PAYTM):

Founded in 2000 by One 97 Communications Limited, Paytm has evolved into one of India’s most extensive digital ecosystems, serving both consumers and merchants. With over 30 crore users and more than 2 crore merchants, Paytm has been at the forefront of India’s digital payment revolution. Its mobile app facilitates a wide range of consumer payments: mobile recharges, utility bills, education fees, ticket bookings, and peer-to-peer transfers through instruments like UPI, cards, and net banking.

Paytm offers QR codes, POS devices, and Soundbox devices for merchants that support digital collections and enhance payment reconciliation. This generates revenue via merchant discount rates (MDR), convenience fees, and subscription models. The platform also supports online and omnichannel merchants through payment gateways.

Beyond payments, Paytm has built a robust financial services arm, offering credit distribution, insurance, and wealth management through its digital lending platform in partnership with financial institutions. It earns revenue from loan sourcing, collection, and marketing services.

Short-Term Drivers Of The 29% Growth:

The shares of Paytm’s parent company witnessed a consistent upward trend over the last four weeks and gave a return of nearly 29% as of 15th April 2025. In the initial hours of the next trading session (16th April), the stock recorded a 3% raise taking the intraday high at Rs.869.45 at around 11.30 a.m.

This growth over the past month can be attributed to the recent deals locked by the company and other key short-term catalysts that instilled positive sentiment among investors. 

1. Increased Stake By Domestic Mutual Funds:

During the March quarter, domestic mutual funds raised their holding in Paytm to an all-time high of 13.1%. This increase was primarily driven by prominent players like Nippon India Mutual Fund and Motilal Oswal Mutual Fund, which increased their stakes by 0.4 and 0.2 percentage points, respectively. Overall institutional ownership, including domestic and foreign entities, rose by approximately 1 percentage point to 69%. 

Other domestic institutions also showed growing interest: five new insurance companies came on board, raising their combined stake to 28 lakh shares. Alternative Investment Funds (AIFs) added two new entities and increased their holdings from 22 lakh to 28 lakh shares.  (source: Mint)

2. Subsidiary Getting Approval:

On 18th March, Paytm’s subsidiary, Paytm Money, received SEBI approval to operate as a registered Research Analyst. This allows the platform to offer investment research and data-backed insights, opening up a new revenue stream. Post announcement, the stock rebounded from its 200-day moving average of Rs.690, closing higher at Rs.735.6. (Source: CNBC)

3. ESOP Allotments:

Under the Employee Stock Option Plan, employees can purchase company shares at a predetermined price (often lower than market value) after a vesting period. As of 9th March 2025, Paytm allotted 84,793 equity shares under ESOP 2019 and ESOP 2008. This move slightly expanded the company’s share capital from Rs.63.76 crore to Rs.63.77 crore.

While the allotment was modest, the market responded positively, with the stock gaining 3% as of 11th March 2025. Later, on 27th March, the fintech firm announced the allotment of 93,219 more equity shares under ESOP 2019.  (Source: CNBC)

4. Paytm and GHMC Partnership:

Paytm partnered with the Greater Hyderabad Municipal Corporation (GHMC) to streamline property tax collection by deploying over 400 All-In-One EDC devices. These machines allow residents to pay using cards or QR codes and integrate with the GHMC app for real-time verification and receipts. Following this announcement, Paytm’s closing stock price rose from Rs.783.45 on 1st April to Rs.801.10 on 2nd April, up by around 2.25%.

5. Paytm Partnership With SBI Mutual Fund:

Paytm announced a partnership with SBI Mutual Fund on 18th March 2025 to launch the JanNivesh Rs.250 SIP. It is an initiative to enable users to invest in mutual funds with just Rs.250. This collaboration supports the government’s mission of enhancing financial literacy and inclusion.

Long-Term Underlying Factors Of Growth For Paytm:

Over the last three years, the stock has garnered a return of 26.74% and 123.81% over the past one year as of 16th April 2025. Over the years, the company’s gradual recovery from past disruptions and regulatory scrutiny has been a key growth driver. Apart from this, the other primary drivers for this growth are as follows-

Revenue Growth:

The financial performance of Paytm over the last five financial years (FY2020- FY2024), along with the most recent quarterly data, reveals a consistent pattern of revenue growth. Concurrently, the company’s net losses have shown a general trend of decrease over the same tenure. 

Improved Operational Efficiency:

The recent annual assessment of Paytm (Annual report for FY2024) highlighted the company’s growing efficiency in all of its business segments. 

Payment Services: 

This segment witnessed a 26% revenue growth in FY2024, reaching Rs.6,236 crore. A significant driver for this growth was the deployment of payment devices, which rose to 107 lakh in March 2024 from 68 lakh in the previous year. This expansion directly translates to higher subscription revenues, indicating a strong operational improvement in merchant acquisition and engagement. The payments margin also improved significantly by 50% year-over-year to Rs.2,955 crore in FY 2024, showcasing enhanced efficiency in payment processing.   

Financial Services: 

Paytm’s loan distribution business has scaled with a 48% year-over-year growth in FY2024, disbursing loans worth Rs.52,390 crore. The revenue from Financial Services & Others also saw an increase of 30% year-over-year, reaching Rs.2,004 crore in FY2024.   

Marketing Services: 

This segment also contributed to the overall growth, with a 14% increase in revenue, reaching Rs.1,738 crore in FY2024.   

Bottomline:

Paytm’s recent stock rally, driven by improved financial performance, strategic partnerships, and growing institutional interest, reflects a renewed confidence in the company’s long-term potential. The company’s diversified ecosystem, expanding user base, and innovative offerings have positioned it as a key player in India’s digital transformation story. Strengths such as technological innovation, a robust partner network, and growing financial metrics are encouraging, while persistent challenges, including regulatory scrutiny, competition, and reliance on domestic markets, remain essential considerations.

The fintech space in India is evolving rapidly, and companies like Paytm are well-poised to capitalize on emerging opportunities. However, given the inherent volatility of the sector and the company’s journey toward sustainable profitability, investors should approach it with cautious optimism. It is thus essential to conduct thorough personal research and consider your financial goals and risk appetite before making any investment decisions. 

Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis – Research & Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL & the certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.

The stock market has witnessed heightened activity with a 3% jump in Bajaj Housing Finance shares. Approximately 529 crore shares, representing approximately 64% of the company’s total equity, have been unlocked for trading as the one-year shareholder lock-in period ends. This milestone has sparked curiosity among investors and market enthusiasts alike. But what does this mean for the company, its shareholders, and the stock market?

Let’s break it down

What is a Lock-In Period?

A lock-in period (an anchor lock-in period) is a predetermined duration during which certain company shares cannot be sold or traded. Usually ranging from 90 to 180 days, this is often implemented after an Initial Public Offering (IPO) to ensure price stability and prevent a sudden influx of shares into the market. Once this period ends, investors can sell their shares, which may influence the stock price due to the increased supply. For Bajaj Housing Finance, this lock-in period lasted one year; now, over 500 crore shares are eligible for trading.

Key Financial Highlights of Bajaj Housing Finance

Bajaj Housing Finance has shown robust growth in its financial metrics:

• Assets Under Management (AUM): The company’s AUM grew by 26% year-on-year, reaching ₹1.14 lakh crore as of March 31, 2025. It was ₹91,370 crore in the previous year.
• Loan Assets: Loan assets also saw a significant increase, standing at ₹99,500 crore compared to ₹79,301 crore in the previous year.
• Gross Disbursements: For the January-March quarter, gross disbursements amounted to ₹14,250 crore, a notable rise from ₹11,393 crore in the same period last year. Source: Money Control

These figures highlight the company’s strong performance and its ability to cater to the growing demand for housing finance products.

The Impact on Bajaj Housing Finance Shares

Bajaj Housing Finance shares have garnered significant attention as the lock-in period ends. The stock is currently trading at ₹119.6 per share, which is over 70% higher than its issue price of ₹70. However, it’s important to note that the end of the lock-in period does not necessarily mean that all unlocked shares will be sold. It simply means that these shares are now eligible for trading.

The company’s shares debuted on the stock exchange at ₹150, as the ₹6,560 crore initial public offering (IPO) in 2024 saw a strong response from investors, with total subscriptions reaching an impressive ₹3.23 lakh crore. The IPO included a fresh equity issue worth ₹3,560 crore and an offer-for-sale (OFS) of ₹3,000 crore by its parent company, Bajaj Finance. However, despite this substantial rise, they are still trading below the listing price. This mixed performance has led to varied opinions among analysts and investors. 

As of 14 April 2025, shares of Bajaj Housing Finance were trading 3.3% higher at ₹123.3. While the stock is below its post-listing peak of ₹188, it continues to trade well above its IPO price of ₹70 per share. Source: CNBC TV18

What Does This Mean for Investors?

Unlocking shares has led to heightened trading activity and increased market interest. However, it’s crucial to understand that the end of the lock-in period does not guarantee a sell-off by investors. Many of these shares are held by promoters and group entities, who may choose to retain their holdings.

For retail investors, this development presents both opportunities and risks. While the increased availability of shares could lead to more liquidity and trading options, it could also result in price fluctuations depending on market sentiment.

As per the latest available data for the December 31, 2024 quarter, promoters continue to hold a dominant 88.75% stake in Bajaj Housing Finance.  Source: CNBC TV18

Analyst Opinions

Market analysts have expressed mixed views on Bajaj Housing Finance shares. While some might see growth potential, others remain cautious due to the stock’s current valuation and market conditions. The one-year target price for the stock is ₹108, indicating a potential downside of 13% from current levels.

Conclusion

The end of the lock-in period for Bajaj Housing Finance shares marks a significant milestone for the company and its investors. While the stock has shown robust growth since its IPO, it faces challenges in maintaining its momentum. Investors are advised to conduct thorough research and consult financial experts before making investment decisions.

Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis – Research & Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL & the certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.

FAQs

The Global Tech Reset Comes to India

What began as cautious cost-cutting in Silicon Valley is now a full-blown global workforce reset. Alphabet Inc., the parent company of Google, has extended its layoff strategy to India, marking a sobering moment for the country’s tech sector. The wave is a more significant trend reshaping talent priorities across industries.

While reports from People Matters suggest Google’s India layoffs may be on a limited scale, the implications are far-reaching. They expose the vulnerability of even the most secure jobs and mid-career professionals’ growing discomfort in a world shifting swiftly toward AI, automation, and leaner structures.

What does this signal for the Indian economy and tech employment landscape? Let’s unpack the data and deeper implications.

Global Layoffs—A Structural Correction, Not a Blip

Big Tech firms have continued trimming their workforce well into 2025. As per India Today, companies like Google, Microsoft, Amazon, and Salesforce have each cut hundreds, if not thousands, of roles this year. This trend began in 2022 amid macroeconomic uncertainties and post-pandemic corrections and shows no signs of slowing.

2025 has become the third consecutive year of major tech layoffs. The magnitude of the current wave signals is more than just cyclical corrections; it is structural.

Key Stats:

• Layoffs.fyi reports, over 90,000 tech workers were laid off globally in Q1 2025 alone. 
• The global tech sector saw over 164,000 layoffs in 2022. This climbed to 262,000 in 2023; in 2024, 263,000 layoffs were seen across 1,186 companies globally. 
• Major contributors this year include:
  • Google: 1,000+ (expected globally in Q1–Q2)
  • Microsoft: ~1,900 job cuts in its Azure and mixed reality units
  • Amazon: 18,000+ job cuts since Jan 2023; ~5,000 in early 2025
  • Meta: ~10,000 job cuts between 2023 and early 2025

These layoffs coincide with companies redirecting capital into AI integration, cloud computing, and lean business models—a shift often sidelines experienced professionals who aren’t upskilling fast enough. 

Google’s Layoffs in India—Limited but Symbolic

According to Business Standard, Google’s layoffs in India are expected to affect a small subset of employees across sales, operations, and support functions, with restructuring targeting non-core teams or duplicated roles. However, even “limited impact” has strategic significance.

Why Now?

• Efficiency over Expansion: Google is under pressure to boost operating margins, with its Q4 2024 earnings showing a dip in cloud profitability despite overall revenue growth.
  
• AI Integration: Massive investments in Gemini (Google’s AI suite) demand reallocation of human capital.
  
• Role Redundancy: Post-pandemic decentralization led to team overlaps globally, including in India. 

For India, where global captives (GCCs) like Google, Amazon, and Meta offer premium employment, this move shatters the assumption of immunity from global headwinds. 

Layoffs in Their 40s—A Generational Crossroad

One of the most troubling patterns emerging from the current layoff wave is the growing vulnerability of professionals in their 40s. According to Bombay Shaving Company CEO Shantanu Deshpande, this age cohort is increasingly being “optimized out” due to high cost and perceived rigidity.

Why Are 40-Somethings at Risk?

• Higher CTCs: Salaries of mid-level managers in India can be 3–5x that of fresh hires with AI/ML skill sets.
  
• Skill Obsolescence: The fast pace of tech transformation, especially with AI and automation, disproportionately affects those whose skills have not evolved at the same pace. The average half-life of a tech skill is now just 2.5 years (World Economic Forum).
  
• Cultural Shifts: Younger workforces are seen as more adaptable and tech-native in lean organizations. 

This trend raises concerns about India’s aging skilled workforce, who may find it challenging to re-enter the job market or transition into new tech-driven roles. Economically, this poses a dual challenge for India: it risks eroding a key consumption class and amplifying social insecurities in upper-middle-income urban cohorts. 

India Inc Layoffs—The Domestic Corporate Story

While MNCs are making headlines, Indian corporates are also undergoing a quiet layoff cycle. Companies across e-commerce, fintech, and edtech have trimmed headcount to preserve capital amidst funding droughts.

Key Stats:

• Byju’s has let go of over 10,000 employees in waves since 2023. 
• Swiggy, Ola, and Unacademy each have a 10–30% staff reduction. 
• Indian IT firms (TCS, Infosys, Wipro) have slowed hiring and quietly deferred offers in bulk. 

Why It Matters:

• India’s GDP Growth (estimated at 6.8% in FY25) depends on sustained private consumption, which layoffs jeopardize. 
• Urban Real Estate, retail, and credit demand are all susceptible to slowdown as job losses dent confidence. 
• Decline in Consumer Confidence: Layoffs in reputed firms create fear among professionals, prompting a pullback in discretionary spending—particularly in urban centers like Bengaluru and Hyderabad.
• Talent Market Displacement: A surge in mid-career professionals seeking re-employment can distort wage structures and increase competition in freelance or contract roles.
• Re-skilling Demand Surge: There is mounting pressure on India’s ed-tech and skilling ecosystem to prepare this cohort for AI-driven roles. Government schemes and private platforms will need to step in.

The Effects of These Layoffs—A Structural Workforce Shift

India’s digital economy is projected to reach $1 trillion by 2030, but this growth will require balancing youthful innovation and experienced leadership. The layoffs may create a productivity vacuum if seasoned professionals are pushed out without viable transitions. The ongoing layoffs are catalyzing a fundamental reconfiguration of India’s white-collar workforce:

1. Re-skilling Pressure: To stay relevant, Workers must upskill every 18–24 months. Data engineering, GenAI tools, and cloud certifications are in high demand.

2. Contractual Hiring Surge: More firms are adopting gig and project-based hiring models. NITI Aayog expects India’s gig workforce to reach 23.5 million by 2030, up from 7.7 million in 2022.

3. Mental Health Crisis: Job insecurity, especially for those in their peak earning years, is creating a silent mental health challenge, often under-addressed in workplace policies.

How Professionals Can Avoid the Axe

While no job is future-proof, employees can take strategic steps to reduce vulnerability:

Continuous Learning

• Focus on high-growth domains: AI, cybersecurity, data science, and business analytics.
• Platforms like Coursera, Udemy, and Great Learning offer industry-recognized certifications. 

Build Internal Mobility

• Volunteer for cross-functional projects.
• Demonstrate flexibility and adaptability in internal reviews.
  

Personal Branding

• Regularly update LinkedIn with achievements, not just roles. 
• Showcase thought leadership via blogs, webinars, or podcast appearances.
  

Financial Planning

• Maintain an emergency fund (ideally 6–9 months of expenses).
• Avoid lifestyle inflation tied to role or title. 

Mentorship & Networks

• Engage with industry bodies like NASSCOM, CII, or TiE. 
• Develop internal advocates across levels. 

A Make-or-Break Moment for India’s Workforce Strategy

The arrival of Google’s layoffs in India is not just a corporate event—it is a macro signal. In the age of AI, efficiency metrics, structural shifts, age, and experience are no longer insulated from disruption.

India must urgently reimagine workforce planning at the policy and corporate level. For professionals, the message is clear: adaptability, not experience, will be the new currency of survival.

Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis – Research & Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL & the certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.

This week is packed with significant corporate actions that investors should know. From dividends and stock splits to spin-offs and rights issues, several companies are making moves that could impact shareholder value.

Tata Consultancy Services (TCS), India’s largest IT services firm, has declared its highest-ever final dividend. The company will distribute a total of ₹44,962 crore to its shareholders as dividends.

Thirteen other companies, including CRISIL, Hexaware, and Quess Corp, have also announced key corporate actions. Each company has set a weekly record date to identify eligible shareholders for these benefits. Under the T+1 settlement cycle, investors must hold the shares at least one day before the ex-date to qualify. Source: Economic Times

 Let’s delve into the details of these actions to help you stay informed and make strategic investment decisions.​

Understanding Corporate Actions

Corporate actions like dividends, stock splits, and rights issues can significantly impact a company’s stock price and investor returns. Here’s a brief overview:

Dividends:
A company’s Dividends are periodic payments to its shareholders, typically from its net profits. They reward investors for holding the stock, which can be issued in cash or additional shares, reflecting the company’s financial strength and profitability.

Stock Splits:
A stock split increases the number of outstanding shares by dividing each share, which lowers the price per share. While the company’s overall value remains unchanged, it improves stock liquidity and makes shares more affordable for small investors.

Rights Issues:
Rights issues allow existing shareholders to purchase additional shares at a discounted rate before they are offered to the public. This helps companies raise capital while allowing loyal shareholders to maintain or increase their ownership.

Spin-Offs:
A spin-off occurs when a company creates a new, separate entity by distributing shares of the new business to existing shareholders. It allows the parent company to focus on core operations while unlocking value in non-core segments for investors.

TCS Declares Record ₹126 Dividend for FY25

Tata Consultancy Services (TCS) has announced its highest-ever final dividend of ₹30 per share for FY25, taking the total annual dividend to ₹126 per share. This includes three interim dividends of ₹10 each and a special dividend of ₹66. 

The 3000% final dividend, based on a face value of ₹1, brings the total shareholder payout for the year to ₹44,962 crore. However, it has not yet specified the record date for eligibility. 

In 2024, TCS announced its January–March quarter results on April 12 and declared a final dividend of ₹28 per share. The record date for this was set nearly a month later, on May 16. Based on this pattern, it is likely that TCS will follow a similar timeline this year, with the FY25 dividend record date expected to be announced in May. ET Now/Tata Consultancy Services

Mazagon Dock Shipbuilders’ Final Dividend and Stock Split

Mazagon Dock Shipbuilders, a leading defense PSU, has declared an interim dividend of ₹3 per share. The company has set Wednesday, April 16, as both the ex-date and record date to determine eligible shareholders for this payout.

Quess Corp’s Spin-Off

April 15 has been set as both the ex-date and record date for Quess Corp’s demerger. The leading business services firm is entering a new growth phase, with its approved spin-off resulting in three publicly listed companies. Following NCLT approval, Quess Corp has formalized this much-anticipated business split timeline. Source: Financialexpress.com

Other Noteworthy Corporate Actions

1) CRISIL
The record date for CRISIL’s final dividend of ₹26 per share is Monday, April 14. The ex-date was Friday, April 11.

2) Energy Infrastructure Trust
The ex-date and record date for income distribution (InvIT) is set for Tuesday, April 15.

3) Hexaware Technologies
Hexaware will conduct an interim dividend payout of ₹5.75 per share. The ex-date and record date are both on April 15.

4) Kapil Raj Finance
Kapil Raj Finance has announced a 1:10 stock split, with April 15 as the ex-date and record date.

5) Onesource Industries and Ventures
April 15 has been set as the ex-date and record date for the company’s rights issue.

6) Remedium Lifecare
The rights issue of Remedium Lifecare will also have April 15 as its ex-date and record date.

7) Akme Fintrade (India)
Akme Fintrade will undergo a 1:10 stock split. The ex-date is Thursday, April 17, and the record date is Friday, April 18.

8) Garment Mantra Lifestyle
The ex-date and record date for Garment Mantra’s rights issue is Thursday, April 17.

9) Rushabh Precision Bearings
The company has set April 17 as the ex-date and record date for implementing its resolution plan (suspension).

10) Sanofi Consumer Healthcare India
Sanofi has announced a final dividend of ₹55 per share, with April 17 as the ex-date and record date.

11) Tirupati Tyres
April 17 is the ex-date and record date for Tirupati Tyres’ rights issue.

​The Economic Times/The Financial Express

Key Takeaways for Investors

• Stay Informed: Keep track of record dates and ex-dates to ensure eligibility for dividends and other benefits.​
• Assess Impact: Evaluate how corporate actions align with your investment strategy and financial goals.
• Consult Professionals: When in doubt, seek advice from financial advisors to navigate complex corporate actions.​

Markets Rebound Sharply on Friday

With several corporate actions lined up this week, let’s look at how the market performed last week and what experts predict for the weeks ahead.

Despite the weak weekly trend, Indian markets staged a powerful rally on 11th April 2025. The BSE Sensex jumped by 1,310.11 points (1.77%) to close at 75,157.26, while the Nifty 50 rose 429.40 points (1.92%), ending at 22,828.55. Buying interest was strong across sectors, with BFSI and auto stocks leading the charge. 

Indian benchmark indices closed the week with a marginal decline of 0.3%, weighed down by heightened volatility due to mixed signals from former U.S. President Donald Trump on reciprocal tariffs. His fluctuating stance on trade relations added to the global market’s nervousness.

According to experts, volatility may persist in the coming week as the US-China trade war escalates. With both countries imposing retaliatory tariffs, markets will likely remain under pressure. Source: Economic Times

Conclusion

The upcoming week presents several corporate actions that could impact investor portfolios. TCS’s substantial dividend underscores its strong financial performance, while Mazagon Dock’s dividend and stock split reflect its growth trajectory. Quess Corp’s spin-off indicates a strategic realignment to enhance shareholder value. Staying informed about these developments is crucial for investors to make timely and informed investment decisions.​

Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis – Research & Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL & the certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.

FAQs